Teleflex (TFX) Stock Price, News & Analysis

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" TFX shares.
View TFX analyst ratings or view top-rated stocks.

10 analysts have issued 12-month price targets for Teleflex's shares. Their TFX share price targets range from $225.00 to $293.00. On average, they anticipate the company's share price to reach $267.50 in the next twelve months. This suggests a possible upside of 28.5% from the stock's current price.
View analysts price targets for TFX or view top-rated stocks among Wall Street analysts.

Teleflex's stock was trading at $249.34 at the beginning of the year. Since then, TFX shares have decreased by 16.5% and is now trading at $208.24.
View the best growth stocks for 2024 here.

Teleflex saw a decrease in short interest in March. As of March 15th, there was short interest totaling 817,200 shares, a decrease of 42.0% from the February 29th total of 1,410,000 shares. Based on an average daily volume of 250,100 shares, the short-interest ratio is currently 3.3 days.
View Teleflex's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our TFX earnings forecast.

Teleflex Incorporated (NYSE:TFX) posted its quarterly earnings data on Thursday, February, 22nd. The medical technology company reported $3.38 earnings per share for the quarter, beating analysts' consensus estimates of $3.26 by $0.12. The medical technology company had revenue of $773.90 million for the quarter, compared to analyst estimates of $769.01 million. Teleflex had a trailing twelve-month return on equity of 14.98% and a net margin of 11.98%. The company's revenue was up 2.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.52 earnings per share.
Read the conference call transcript.

Teleflex declared a quarterly dividend on Thursday, February 22nd. Stockholders of record on Friday, March 1st will be paid a dividend of $0.34 per share on Friday, March 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.65%. The ex-dividend date of this dividend is Thursday, February 29th.
Read our dividend analysis for TFX.

Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.63%. The dividend payout ratio is 18.06%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 8.95% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

ETFs with the largest weight of Teleflex (NYSE:TFX) stock in their portfolio include ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), First Trust Indxx Medical Devices ETF (MDEV), SPDR S&P Health Care Equipment ETF (XHE), Invesco S&P 500 Equal Weight Health Care ETF (RYH), Invesco S&P 500 Equal Weight Health Care ETF (RSPH), iShares U.S. Medical Devices ETF (IHI), T. Rowe Price Capital Appreciation Equity ETF (TCAF) and Mid Cap US Equity Select ETF (RNMC).

Teleflex updated its FY24 earnings guidance on Thursday, February, 22nd. The company provided earnings per share guidance of $13.55-$13.95 for the period, compared to the consensus EPS estimate of $13.73.

73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).

Teleflex's stock is owned by many different institutional and retail investors. Top institutional shareholders include Mountain Pacific Investment Advisers Inc. ID (0.17%), Bridge Creek Capital Management LLC (0.03%), Rowlandmiller & PARTNERS.ADV (0.02%), Congress Asset Management Co. MA (0.01%), Washington Capital Management Inc. (0.01%) and Thompson Investment Management Inc. (0.01%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell.
View institutional ownership trends.

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.